Kinin Formation in Human Blood Serum Induced by Cooling and by Heat Aggregated Human Gamma Globulin Preparations

  • Désirée Armstrong
  • W. Dias da Silva
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 8)


The original kinin research at the Middlesex Hospital Medical School concerned, for many years, the occurrence of plasma kinin when the human plasma touched foreign surface such as glass (Armstrong et al, 1952, 1957; Keele & Armstrong, 1964; Armstrong, 1968a). More recently the work has centered upon the spontaneous occurrence of kinins when the human plasma (heparinized or citrated) or serum is cooled, e.g. 370 – 00 C, without contact with glass (Armstrong & Mills, 1965; Armstrong et al, 1967; Armstrong, 1968a,c). Although not all kinins are pa in-producing (see Armstrong, 1968a,c) the kinin produced by cooling of the human serum is, and in this it resembles the kinin induced by glass exposure of the serum. Both the kinin formation induced by glass and that induced by the cold exposure of serum are Hageman Factor dependent reactions (Margolis, 1957, 1958a,b, 1960; Armstrong, 1968c; see also Armstrong et al, 1967; Armstrong, 1968a,b and 1969a). They thus resemble one another and also the kinin formation induced by antigen-antibody precipitates (Movat, 1967; Movat et al, 1968; Boreham & Goodwin, 1969) which appears to be a Hageman Factor dependent reaction also.


Human Plasma Cold Exposure Normal Human Serum Human Complement Esterase Inhibitor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. ARMSTRONG, D. (1968a). Pain. In: Heffter’s Handbuch der experimentellen Pharmakologie : Bradykinin : Kai lidin : Kallikrein. Ed. Erdös, E.G. New York : Springer Verlag. In the Press.Google Scholar
  2. ARMSTRONG, D. (1968b). The effects of temperature on the response of human plasma kinin-forming system to promoting and inhibiting agents. Br. J. Pharmac. 34, 670P.Google Scholar
  3. ARMSTRONG, D. (1968c). Hageman Factor and the spontaneous human plasmakinin generation occurring in homogeneous media. Activation and inactivation. In: Inflammation, Biochemistry and Drug Interaction. Ed. Bertelli, A. and Houck, C. Excerpta Medica Founcation, Amsterdam. In the Press.Google Scholar
  4. ARMSTRONG, D. (1969). Actions on the human cold-activated plasma kinin-forming system of pre-heating at 56° and 60°C. Pharm. Res. Comm. 1, 30–35.CrossRefGoogle Scholar
  5. ARMSTRONG, D. & Dias da Silva, W. (1968). Unpublished observations.Google Scholar
  6. ARMSTRONG, D. & Dias da Silva, W. (1969). Kinin formation in human blood serum induced by cooling and by heat-aggregated human gamma globulin preparations, HAHGG. Pharm. Res. Comm. 1, 132–134.CrossRefGoogle Scholar
  7. ARMSTRONG, D., DRY, R.M.L., KEELE, C.A. & Markham, J.W. (1952). Pain-producing substances in blister fluid and in serum. J. Physiol. 117, 4P.Google Scholar
  8. ARMSTRONG, D., JEPSON, J.B., KEELE, C.A. & STEWART, J.W. (1957). Pain-producing substance in human inflammatory exudates and plasma. J. Physiol. 135, 350–370.PubMedGoogle Scholar
  9. ARMSTRONG, D.A.J. & MILLS, G.L. (1964). A highly purified kinin-forming enzyme from human plasma. Biochem. Pharmacol. 13, 1393–1402.PubMedCrossRefGoogle Scholar
  10. ARMSTRONG, D. & MILLS, G.L. (1965). The reversible cold-induced activation of the human plasma kinin-forming system between 37 and 0 C. J. Physiol. 179, 89–90P.Google Scholar
  11. ARMSTRONG, D., MILLS, G.L. & SICUTERI, F. (1966). Physiological influence on the liberation of human plasma kinin at low temperatures. In: Symposium on Hypotensive Peptides. Ed: Erdös, E.G., N. Back, and F. Sicuteri. pp. 139–148. New York : Springer Verlag.CrossRefGoogle Scholar
  12. ARMSTRONG, D., MILLS, G.L. & STEWART, J.W. (1967). Thermally induced effects on the kinin-forming system of native human plasma, 37°-0°C. and 37°-50°C. In: International Symposium on Vaso-active Polypeptides; Bradykinin and Related Kinins. Ribeirão Prêto, August 1966; 167–176. Eds: Rocha e Silva, M. and H.A. Rothschild. São Paulo: Soc. Bras. Farmacologia e Terapeutica Experimental.Google Scholar
  13. BOREHAM, P.F.L. & GOODWIN, L.G. (1969). The release of kinins as the result of an antigen-antibody reaction in trypanosomiasis. Pharm. Res. Comm. 1, 144–145.CrossRefGoogle Scholar
  14. DAVIES, E.E. & LOWE, J.S. (1960). A permeability factor released from guinea-pig serum by antigen-antibody precipitates. Brit. J. exp. Path. 41, 325–344.Google Scholar
  15. DONALDSON, V.H. (1968). Mechanisms of activation of CM esterase in hereditary angioneurotic oedema plasma in vitro. The role of Hagemon Factor, a clot-promoting agent. J. exp. Med. 127, 411–429.PubMedCrossRefGoogle Scholar
  16. DONALDSON, V.H. & RATNOFF, O.D. (1963) Hageman Factor: Alterations in physical properties during activation. Science 150, 754–756.CrossRefGoogle Scholar
  17. DONALDSON, V.H., RATNOFF, O.D. & ROSEN, F.S. (1965). Permeability properties of plasma in hereditary angioneurotic oedema. J. lab. clin. Med. 66, 867.Google Scholar
  18. EISEN, V. (1963). Observations on intrinsic kinin-forming factors in human plasma: The effect of acid, acetone, chloroform, heat and euglobulin separation on kinin formation. J. Physiol. 166, 496–513.PubMedGoogle Scholar
  19. FRIEDBERGER, E. & ITO, T. (1911). Über Anaphylaxie: XXI. Mitteilung. Näheres über den Mechanismus der Komplementwirkung der Anaphyla-toxinbildung in vitro. Z. Immun. -Forsch. 11, 471–478.Google Scholar
  20. HEIDELBERGER, M. (1941). Quantitative chemical studies on complement or alexin. I. A Method. J. exp. Med. 73, 681–694.PubMedCrossRefGoogle Scholar
  21. HEIDELBERGER, M., ROCHA E SILVA, M. & Mayer, M.M. (1941). Quantitative chemical studies on complement or alexin. III. Uptake of complement nitrogen under varying experimental conditions. J. exp. Med. 74, 359–367.PubMedCrossRefGoogle Scholar
  22. KEELE, C.A. & ARMSTRONG, D. (1964). Substances producing pain and itch. London: Edward Arnold Ltd.Google Scholar
  23. LEPOW, I.H., NAFF, G.B., TODD, E.W., PENSKY, J. & HINZ, Jr., C.F. (1963). Chromatographic resolution of the first component of human complement into three activities. J. exp. Med. 117, 983–1008.PubMedCrossRefGoogle Scholar
  24. LEPOW, I.H., NAFF, G.B., & PENSKY, J. (1965). Mechanisms of activation of C’l and inhibition of C’l esterase. In: Ciba Foundation Symposium on Complement, 1965, pp. 74–90. Ed: Wolstenholme, G.E.W. and J. Knight. J. &A. Churchill Ltd., London.CrossRefGoogle Scholar
  25. LEPOW, I.H., RATNOFF, O.D. & PILLEMER, L. (1956). Elutionofan esterase from antigen-antibody aggregates treated with human complement. Proc. Soc. exp. Biol. Med. 92, 111–114.PubMedGoogle Scholar
  26. MARGOLIS, J. (1957). Initiation of blood coagulation by glass and related surfaces. J. Physiol. 137, 95–109.PubMedGoogle Scholar
  27. MARGOLIS, J. (1958b). Activation of plasma by contact with glass: evidence for a common reaction which releases plasma kinin and initiates coagulation. J. Physiol. 144, 1–22.PubMedGoogle Scholar
  28. MARGOLIS, J. (1958a). Hageman Factor in plasma foreign surface reactions. Nature (Lond.) 182, 1102–1103.CrossRefGoogle Scholar
  29. MARGOLIS, J. (1960). The mode of action of Hageman Factor in the release of plasma kinin. J. Physiol. 151, 238–252.PubMedGoogle Scholar
  30. MOVAT, H.Z. (1967). Activation of the kinin system by antigen-antibody complexes. In: International Symposium on Vaso-active Polypeptides : Bradykinin and related Kinins. Ribeirãb Prêto; August, 1966. pp. 177–188. Ed: Rocha e Silva, M. & H.A. Rothschild. São Paulo: Soc. Bras. Farmacologia e Therapêutica Experimental.Google Scholar
  31. MOVAT, H.Z., DILORENZO, N.L. & TRELOAR, M.P. (1968). Activation of the plgsma kinin system by antigen-antibody aggregates. II. Isolation of permeability-enhancing and kinin-releasing fractions from activated guineapig serum. Lab. Invest. 19, 201–210.Google Scholar
  32. NAFF, G.B., PENSKY, J. & LEPOW, I.H. (1964). The macromolecular nature of the first component of human complement. J. exp. Med. 119, 593–613.PubMedCrossRefGoogle Scholar
  33. NOSSEL, H.L. & NIEMETZ, J. (1965). A normal inhibitor of the blood coagulation contact reaction product. Blood, 25, 712–723.PubMedGoogle Scholar
  34. PENSKY, J. (1969). Personal communicationGoogle Scholar
  35. PENSKY, J., LEVY, L.E. & LEPOW, I.H. (1961). Partial purification of a serum inhibitor of C’l esterase. J. biol. Chem. 236, 1674–1679.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1970

Authors and Affiliations

  • Désirée Armstrong
    • 1
    • 2
  • W. Dias da Silva
    • 1
    • 2
  1. 1.The Middlesex Hospital Medical SchoolLondonEngland
  2. 2.Federal University of Minas GeraisBelo HorizonteBrazil

Personalised recommendations